EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

USP6NL and MSX2 as the novel diagnostic markers in gastric cancer patients

Zahra Basirat, Negin Taghehchian, Mohammad Reza Abbaszadegan, Meysam Moghbeli

Cancer Treatment and Research Communications · 2025

DOI: 10.1016/j.ctarc.2025.100977 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Treatment and Research Communications, 2025. Verfasst von Zahra Basirat und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Stomach Neoplasms, Biomarkers, Tumor, Homeodomain Proteins, Ubiquitin Thiolesterase. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Mashhad University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastric cancer (GC) is one of the most frequent gastrointestinal malignancies in the world. WNT signaling pathway has a key role in the occurrence and progression of GC. USP6NL belongs to the GAP protein family that regulates the WNT signaling by the β-catenin stabilization during tumor progression. Therefore, for the first time in the present study, we examined the role of USP6NL in tumor progression through the regulation of WNT signaling pathway among GC patients. C-MYC and MSX2 were also assessed in GC patients as the WNT target genes to evaluate the role of USP6NL during GC progression via WNT regulation. Eighty-three freshly tumor and corresponding normal tissues were enrolled to assess the levels of USP6NL, MSX2, and C-MYC mRNA expressions using the Real time polymerase chain reaction. There was significant higher levels of USP6NL in non-cardia compared with cardia tumors (p = 0.03). There was also significant higher levels of USP6NL expressions in non-cardia tumors of females compared with males (p = 0.032). Low-grade tumors with MSX2 up regulation were significantly associated with low survival (p = 0.012). MSX2 up regulation was significantly correlated with lower survival among the female GC patients (p = 0.041). The levels of USP6NL was also significantly correlated with the levels of MSX2 (p ≤ 0.0001) and C-MYC (p = 0.001). USP6NL/MSX2/C-MYC axis can be introduced as a reliable diagnostic marker or therapeutic target in GC following the further in-vitro and animal studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsBiomarkers, TumorHomeodomain ProteinsUbiquitin ThiolesteraseHumansMaleFemaleMiddle AgedAgedWnt Signaling PathwayAdultGene Expression Regulation, NeoplasticProto-Oncogene Proteins c-mycPrognosis

Stichwörter der Autor:innen

C-MYCGastric cancerMSX2USP6NLWNT signaling

Substanzen

Biomarkers, TumorMSX2 proteinHomeodomain ProteinsProto-Oncogene Proteins c-mycUbiquitin Thiolesterase

Autor:innen und Institutionen

  • Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: moghbelim@mums.ac.ir.

Förderung

  • Mashhad University of Medical Sciences

Zitieren

APA

Basirat, Z., Taghehchian, N., Abbaszadegan, M. R., & Moghbeli, M. (2025). USP6NL and MSX2 as the novel diagnostic markers in gastric cancer patients. Cancer Treatment and Research Communications. https://doi.org/10.1016/j.ctarc.2025.100977

Vancouver

Basirat Z, Taghehchian N, Abbaszadegan MR, Moghbeli M. USP6NL and MSX2 as the novel diagnostic markers in gastric cancer patients. Cancer Treatment and Research Communications. 2025. doi:10.1016/j.ctarc.2025.100977

BibTeX
@article{Basirat2025,
  author = {Basirat, Zahra and Taghehchian, Negin and Abbaszadegan, Mohammad Reza and Moghbeli, Meysam},
  title = {USP6NL and MSX2 as the novel diagnostic markers in gastric cancer patients},
  journal = {Cancer Treatment and Research Communications},
  year = {2025},
  doi = {10.1016/j.ctarc.2025.100977}
}
Kostenlos starten →